Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MYND Life Sciences (TSE:MYND)
:MYND
MYND Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.14
Previous CloseN/A
Volume0.00
Average Volume (3M)2.75K
Market Cap
$5.02M
Enterprise ValueC$4.85M
Total Cash (Recent Filing)$1.90M
Total Debt (Recent Filing)$2.25M
Price to Earnings (P/E)―
Beta-0.75
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding47,817,180
10 Day Avg. Volume5,561
30 Day Avg. Volume2,753
Standard Deviation0.50
R-Squared0.01
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1001.80
P/FCF Ratio34.60
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue4.85M
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-15.85
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MYND Life Sciences News
PremiumCompany Announcements
MYND Life Sciences Strengthens Finances and Leadership
PremiumCompany Announcements
MYND Life Sciences Restructures Debt with Share IssuanceMYND FAQ
What was MYND Life Sciences’s price range in the past 12 months?
MYND Life Sciences lowest stock price was C$0.01 and its highest was C$0.14 in the past 12 months.
What is MYND Life Sciences’s market cap?
MYND Life Sciences’s market cap is $5.02M.
When is MYND Life Sciences’s upcoming earnings report date?
MYND Life Sciences’s upcoming earnings report date is Mar 04, 2025 which is in 34 days.
How were MYND Life Sciences’s earnings last quarter?
MYND Life Sciences released its earnings results on Oct 01, 2024. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
Is MYND Life Sciences overvalued?
According to Wall Street analysts MYND Life Sciences’s price is currently Overvalued.
Does MYND Life Sciences pay dividends?
MYND Life Sciences does not currently pay dividends.
What is MYND Life Sciences’s EPS estimate?
MYND Life Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MYND Life Sciences have?
MYND Life Sciences has 47,817,180 shares outstanding.
What happened to MYND Life Sciences’s price movement after its last earnings report?
MYND Life Sciences reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -50%.
Which hedge fund is a major shareholder of MYND Life Sciences?
Currently, no hedge funds are holding shares in TSE:MYND
---
Company Description
MYND Life Sciences
MYND Life Sciences Inc is a life science based, neuro-pharmaceutical drug development company. It is advancing medicines based on neuro-anti-inflammatory substances through rigorous science with an initial focus on major depressive disorder. The company's mission is to further research linking depression and inflammation at the genetic and cellular level to develop a pharmaceutical treatment utilizing compounds found in psychedelics with the initial focus being on psilocybin and its various analogs.
---
Technical Analysis
---